Author

A. Habtezion

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:CITE-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

B. Lee· 2 shared H. Namkoong· 2 shared A. Ganesan· 1 shared A. Kuo· 1 shared D. Dermadi· 1 shared D. Heller· 1 shared D. M. Mikhail· 1 shared G. L. Szot· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. Lee

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJan 21, 2022

Crosstalk of Histone Modifications in the Healthy Human Immune System

D. Dermadi, L. Kalesinskas, A. Ganesan…·P. Khatri

The paper analyzes histone post-translational modifications in human immune cells to uncover their interactions and functional implications.

DOI 10.1101/2022.01.21.477300

humanflow cytometry

𝕏 PostBluesky

ImmunologyGutPeer-reviewedOct 26, 2021

Single-cell sequencing unveils distinct immune microenvironment with CCR6-CCL20 crosstalk in human chronic pancreatitis

B. Lee, H. Namkoong, Y. Yang…·A. Habtezion

This study uses single-cell sequencing to identify distinct immune features and CCR6-CCL20 crosstalk in hereditary versus idiopathic chronic pancreatitis.

DOI 10.1136/gutjnl-2021-324546

𝕏 PostBluesky

ImmunologybioRxivMar 13, 2021

GPR15 in colon cancer development and anti-tumor immune responses.

H. NamKoong, B. Lee, G. Swaminathan…·A. Habtezion

This study investigates the role of GPR15 in colon cancer, showing its deficiency promotes tumor growth by altering immune responses, and identifies GPR15L as a potential therapeutic target.

DOI 10.3389/fonc.2023.1254307

𝕏 PostBluesky